Collaborate Disseminate
Linking exercise with improved mental health outcomes is certainly not a new concept, with previous individual studies looking at the effects of physical activity on schizophrenia, anxiety and depression, as well as analysis of the duration and type of… Continue reading Exercise could be the first line of attack in mental health treatment
When it comes to post-traumatic stress disorder (PTSD), much of the clinical research focuses on improving the condition rather than predicting it. However, a new study carried out at Tufts University has just uncovered a brain marker that seems to sho… Continue reading Brain activity could predict who is most likely to get PTSD
When someone is suffering from post-traumatic stress disorder (PTSD), psychiatrists will sometimes have them actually place themselves in stress-triggering environments. An experimental wearable system has now been shown to make such treatment much mor… Continue reading Wearable tech found to boost real-world treatment of PTSD
Studies continue to illuminate the wide-ranging benefits of physical activity when it comes to brain health, and new research has shown how that might include treatment of post-traumatic stress disorder (PTSD). Scientists have explored how short bursts… Continue reading 10-minute bursts of exercise may boost therapy for PTSD
Striking new research proposes taking a common anti-inflammatory drug soon after experiencing a traumatic event could help people forget upsetting memories and reduce their risk of developing post-traumatic stress disorder (PTSD).Continue ReadingCatego… Continue reading How taking an anti-inflammatory drug after a trauma may prevent PTSD
A first-of-its-kind trial exploring MDMA-assisted therapy in a group setting is about to commence following the resolution of a clinical hold placed by the US Food and Drug Administration (FDA) that paused progress for several months. The goal of the g… Continue reading First-of-its-kind MDMA group therapy trial set to commence
The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving… Continue reading First Phase 3 trial data for MDMA therapy sets path for approval
Surfing the wave of novel research into medical uses for psychedelic compounds, the Icahn School of Medicine at Mount Sinai has launched a dedicated psychedelic center focusing initially on the study of MDMA and psilocybin for PTSD and other stress-rel… Continue reading Psychedelic research center launched at New York’s Mount Sinai
In the late 1970s and early 1980s MDMA was often utilized to help facilitate positive results in couples counseling. A few dozen pioneering psychotherapists in the United States explored the drug’s therapeutic uses until the US government declared MDMA… Continue reading MDMA-assisted couples therapy investigated in landmark pilot trial
The majority of post-traumatic stress disorder (PTSD) patients suffer from frequent traumatic nightmares that can deeply disrupt sleep patterns and have been linked with significantly higher rates of suicide. The U.S. Food and Drug Administration (FDA)… Continue reading FDA approves prescription-only Apple Watch app for PTSD nightmares